Nektar Therapeutics (NKTR) Q4 2023 Earnings

4MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.45
-0.36
-0.28
-0.19

Details

Expected EPS
-0.210442
Actual EPS
-0.22
Surprise EPS
-0.01
Surprise Percent
+4.54%

Description

Nektar Therapeutics (NKTR) has reported earnings of -0.22 per share for Q4 2023.

0 Comments

Share your thoughts